Related Experiment Video
Updated: Jun 21, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Vascular dysfunction in idiopathic dilated cardiomyopathy
Santiago Roura1, Antoni Bayes-Genis
1ICREC Program, Hospital de la Santa Creu i Sant Pau, Institut Català de Ciències Cardiovasculars (ICCC), Barcelona, Spain.
Insights
Idiopathic dilated cardiomyopathy (IDCM) involves heart muscle changes. New research suggests vascular problems, not just heart cell issues, may drive IDCM progression, impacting future therapies.
Area of Science:
- Cardiology
- Vascular Biology
- Pathophysiology
Background:
- Idiopathic dilated cardiomyopathy (IDCM) is characterized by heart muscle dilation and dysfunction without coronary artery disease.
- Traditionally, IDCM focused on cardiomyocyte abnormalities, but cardiac endothelial dysfunction is increasingly linked to disease progression and poor outcomes.
- Patients with IDCM exhibit significant vascular derangements, including impaired vasculogenic and angiogenic responses.
Purpose of the Study:
- To re-examine the pathophysiology of IDCM.
- To investigate the role of vascular derangements as a primary driver of myocyte damage in IDCM.
- To highlight the importance of vascular alterations in understanding IDCM progression.
Main Methods:
- Review of existing data on IDCM pathophysiology.
- Analysis of the association between vascular derangements and cardiomyocyte damage.
- Emphasis on the need for relevant animal models.
Main Results:
- Cardiac endothelial dysfunction and vascular derangements are significantly associated with IDCM progression and prognosis.
- Vascular alterations may precede or contribute significantly to myocyte damage in IDCM.
- Current understanding of IDCM pathophysiology needs to incorporate vascular aspects.
Conclusions:
- IDCM may be viewed as a downstream consequence of underlying vascular derangements.
- Understanding vascular contributions is crucial for developing effective treatments for IDCM.
- Development of animal models with marked vascular alterations is essential for future research and therapeutic testing.
Abstract:
Idiopathic dilated cardiomyopathy (IDCM) is defined as myocardial dilatation and dysfunction in the absence of overt coronary heart disease. Myocardial injury and genetic or environmental factors can lead to the development of IDCM, which was historically characterized by marked abnormalities in the function and integrity of cardiomyocytes. However, cardiac endothelial dysfunction has also been shown to be associated with progression and poor prognosis of IDCM. Moreover, marked vascular derangements and impaired vasculogenic and angiogenic responses have been reported in patients with IDCM. On the basis of these data we re-examine IDCM pathophysiology as a downstream complication of vascular derangements that contribute to myocyte damage. Animal models closely resembling the marked vascular alterations found in patients with IDCM will be of paramount importance for further enhancing our comprehension of disease progression and for testing new drugs and stem-cell or gene-based therapies.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
